找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Recent Advances in Prolactin Research; Maria Diakonova, PhD Book 2015 The Editor(s) (if applicable) and The Author(s), under exclusive lic

[復制鏈接]
樓主: Strategy
31#
發(fā)表于 2025-3-26 21:51:40 | 只看該作者
32#
發(fā)表于 2025-3-27 04:39:30 | 只看該作者
Prolactin-Induced Prostate Tumorigenesis,ors of the PRL signaling axis failed to identify an essential regulatory function on this tissue. However, a large body of evidence suggests an important role for PRL in prostate tumorigenesis. Mainly through the activation of its downstream target STAT5, PRL can induce growth and survival of prosta
33#
發(fā)表于 2025-3-27 06:42:21 | 只看該作者
Prolactin in Inflammatory Response,pathways after binding to its receptor (PRLr) resulting in the activation of specific genes associated with the pleiotropic activities of PLR. To date, various PRLr isoforms have been described, generated by post-transcriptional or post-translational processes. PRL has been associated with the modul
34#
發(fā)表于 2025-3-27 10:55:30 | 只看該作者
A Positive Feedback Loop Between Prolactin and Stat5 Promotes Angiogenesis,escribed that proangiogenic mediators such as fibroblast growth factors can activate members of the signal transducers and activators of transcription (STAT) family. STAT5 activation is necessary and sufficient to induce migration, invasion and tube formation of endothelial cells. STAT5 effects on e
35#
發(fā)表于 2025-3-27 16:44:24 | 只看該作者
36#
發(fā)表于 2025-3-27 21:10:38 | 只看該作者
37#
發(fā)表于 2025-3-27 22:56:26 | 只看該作者
The Many Faces of Prolactin in Breast Cancer,gonist developed by introducing a single amino acid substitution mutation into human PRL (hPRL) at position 129, and a variety of G129R derivatives. The author has proposed two novel ideas for potential use of PRL, not anti-PRL agents, as an adjuvant agent for breast cancer, making it a hormone of many faces.
38#
發(fā)表于 2025-3-28 03:34:39 | 只看該作者
Modeling Prolactin Actions in Breast Cancer In Vivo: Insights from the NRL-PRL Mouse,ndependent from ovarian steroids, and most are ER+. These characteristics resemble the human clinical disease, facilitating study of tumorigenesis, and identification of novel preventive and therapeutic approaches.
39#
發(fā)表于 2025-3-28 09:02:45 | 只看該作者
40#
發(fā)表于 2025-3-28 14:16:19 | 只看該作者
Regulation of Blood Vessels by Prolactin and Vasoinhibins, efficient mechanism for controlling blood vessel growth and function. This review briefly describes the vascular actions of PRL and vasoinhibins, and addresses how their interplay could help drive biological effects of PRL in the context of health and disease.
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-26 01:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
牟定县| 石河子市| 都江堰市| 枞阳县| 南雄市| 邵阳县| 寿阳县| 上饶县| 随州市| 毕节市| 连平县| 沅陵县| 宝丰县| 磴口县| 中西区| 孝昌县| 杭锦后旗| 景德镇市| 桃江县| 财经| 利川市| 白城市| 阿坝县| 舒城县| 旬邑县| 金寨县| 武穴市| 青海省| 枣强县| 寿光市| 楚雄市| 西盟| 临江市| 信阳市| 杂多县| 松江区| 年辖:市辖区| 东乡县| 独山县| 天峻县| 瓮安县|